Indian pharma

“Odisha will be a leading destination for pharmaceutical and medical‑device investments – the most competitive hub for innovation…

According to ratings agency ICRA, revenues for Indian pharma companies are projected to expand by 7-9% in FY2026, supported by…

Anagha Shirur - Adjunct Faculty, K J Somaiya Institute of Management, expresses how lessons from the kirana shops may offer…

Trade generics and Jan Aushadhi are steadily gaining volume share from branded formulations, especially in price-sensitive acute…

Ravi Shah, Partner, Cyril Amarchand Mangaldas explains that while the policy is designed to cut costs for US patients, its effects…

Gross office leasing space by life sciences firms in India increased by ~56 per cent Y-o-Y to 5.8 mn. sq. ft., the highest-ever in…

The Ahmedabad Pharma Summit 2025 brought together policymakers, industry leaders, and innovators to explore pathways for global…

The McKinsey & Company report analyses India’s pharma landscape, highlighting disruptions, opportunities, and strategic…

Dr Sumedha Nadkar, Pharma Consultant and Visiting Faculty, shares a hard-hitting article which highlights that complacency in…

As India positions itself as part of the China+plus one strategy, China has a counter strategy: dumping of low cost imports and…